Cargando…
The safety and tolerability profile of bilastine for chronic urticaria in children
BACKGROUND: Urticaria is a condition defined by the development of wheals, angioedema or both. It is classified based on its duration as acute (≤ 6 weeks) or chronic (> 6 weeks). Chronic urticaria is less frequent than acute one in children, but it represents a debilitating condition, always need...
Autores principales: | Papadopoulos, Nikolaos G., Zuberbier, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806519/ https://www.ncbi.nlm.nih.gov/pubmed/31660121 http://dx.doi.org/10.1186/s13601-019-0294-3 |
Ejemplares similares
-
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013) -
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020) -
Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013) -
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)